427 related articles for article (PubMed ID: 26882847)
41. Decreased expression of lncRNA loc285194 as an independent prognostic marker in cancer: A systematic review and meta-analysis.
Mehrad-Majd H; Ravanshad S; Moradi A; Khansalar N; Sheikhi M; Akhtari J
Pathol Res Pract; 2019 Jun; 215(6):152426. PubMed ID: 31054796
[TBL] [Abstract][Full Text] [Related]
42. Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients.
Huang C; Yu W; Wang Q; Cui H; Wang Y; Zhang L; Han F; Huang T
Minerva Med; 2015 Jun; 106(3):143-9. PubMed ID: 25668599
[TBL] [Abstract][Full Text] [Related]
43. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.
Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM
Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121
[TBL] [Abstract][Full Text] [Related]
44. Upregulation of lncRNA SNHG1 is associated with metastasis and poor prognosis in cancers: A meta-analysis.
Yu J; Yan Y; Hua C; Ming L
Medicine (Baltimore); 2019 Apr; 98(16):e15196. PubMed ID: 31008944
[TBL] [Abstract][Full Text] [Related]
45. Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis.
Wang D; Chen Z; Xu H; He A; Liu Y; Huang W
Oncotarget; 2017 Sep; 8(43):75664-75674. PubMed ID: 29088900
[TBL] [Abstract][Full Text] [Related]
46. Prognostic and clinicopathological value of long noncoding RNA XIST in cancer.
Zhu J; Kong F; Xing L; Jin Z; Li Z
Clin Chim Acta; 2018 Apr; 479():43-47. PubMed ID: 29307668
[TBL] [Abstract][Full Text] [Related]
47. LncRNA BLACAT1 May Serve as a Prognostic Predictor in Cancer: Evidence from a Meta-Analysis.
Lu H; Liu H; Yang X; Ye T; Lv P; Wu X; Ye Z
Biomed Res Int; 2019; 2019():1275491. PubMed ID: 31061820
[TBL] [Abstract][Full Text] [Related]
48. Long noncoding RNA MALAT1 as a putative biomarker of lymph node metastasis: a meta-analysis.
Zhai H; Chen QJ; Chen BD; Yang YN; Ma YT; Li XM; Liu F; Yu ZX; Xiang Y; Liao W; Lai HM
Int J Clin Exp Med; 2015; 8(5):7648-54. PubMed ID: 26221312
[TBL] [Abstract][Full Text] [Related]
49. Prognostic Value of lncRNA PVT1 for Patients with Gastric Cancer: A Meta-Analysis.
Hao J; Yuan B; Gou Y; Ma J; Huang X
Dis Markers; 2021; 2021():5595965. PubMed ID: 34900027
[TBL] [Abstract][Full Text] [Related]
50. Prognostic role of lncRNA TUG1 for cancer outcome: Evidence from 840 cancer patients.
Liu J; Lin J; Li Y; Zhang Y; Chen X
Oncotarget; 2017 Jul; 8(30):50051-50060. PubMed ID: 28548946
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
[TBL] [Abstract][Full Text] [Related]
52. Long noncoding RNA activated by TGF-β in human cancers: A meta-analysis.
Fan YH; Ji CX; Xu B; Fan HY; Cheng ZJ; Zhu XG
Clin Chim Acta; 2017 May; 468():10-16. PubMed ID: 28163033
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis.
Zhu S; Shuai P; Yang C; Zhang Y; Zhong S; Liu X; Chen K; Ran Q; Yang H; Zhou Y
Oncotarget; 2017 Dec; 8(68):113174-113184. PubMed ID: 29348896
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
Zhang XF; Liu T; Li Y; Li S
Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
[TBL] [Abstract][Full Text] [Related]
56. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer.
Huang T; Liu HW; Chen JQ; Wang SH; Hao LQ; Liu M; Wang B
Biomed Pharmacother; 2017 Apr; 88():302-308. PubMed ID: 28122299
[TBL] [Abstract][Full Text] [Related]
57. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion.
Wang Y; Zhou J; Wang Z; Wang P; Li S
Biochem Biophys Res Commun; 2017 Nov; 493(1):429-436. PubMed ID: 28882595
[TBL] [Abstract][Full Text] [Related]
59. lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis.
Chen X; Yang Y; Cao Y; Wu C; Wu S; Su Z; Jin H; Wang D; Zhang G; Fan W; Lin J; Zeng Y; Hu D
Cancer Manag Res; 2018; 10():2711-2727. PubMed ID: 30147369
[TBL] [Abstract][Full Text] [Related]
60. High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
Xu H; Gong J; Liu H
PLoS One; 2017; 12(12):e0189675. PubMed ID: 29244840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
